Ledger.Open graph →
SEC Form D · filed September 2, 2020

Eumentis Therapeutics, Inc

Offering
$3.3M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

James Larrick · Newton, MADirectorMark Tepper · Newton, MAExec · DirectorAndrew Pearlman · Newton, MADirectorRandall Marshall · New York, NYExecCarsten D. Koppen · St Helier, Y9Exec · DirectorMats N. Eklund · St Helier, Y9DirectorThomas Roeder · Nantucket, MADirectorSteve B. Kim · San Mateo, CADirectorS. C. Honig · San Mateo, CAExec · DirectorRobby Peters · San Mateo, CADirectorRandall Marshall · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗